1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
(
- Contribution to journal › Article
- 2018
-
Mark
Advancing the immunoaffinity platform AFFIRM to targeted measurements of proteins in serum in the pg/ml range
(
- Contribution to journal › Article
-
Mark
Combination of phage and Gram-positive bacterial display of human antibody repertoires enables isolation of functional high affinity binders
(
- Contribution to journal › Article
- 2015
-
Mark
A microarray-based reaction rate analysis platform. Is there evidence of validity?
(
- Contribution to journal › Letter
- 2014
-
Mark
AFFIRM – a multiplexed immunoaffinity platform that combines recombinant antibody fragments and LC-SRM analysis
(
- Contribution to journal › Article